Pediatric Randomized Clinical Trials in Community Hospitals: Strategies to Enhance Site Participation and Engagement

Corrie E McDaniel1, Eric R Coon1, Natalia Paciorkowski2

  • 1Department of Pediatrics, Division of Hospital Medicine, University of Washington, Seattle, Washington.

Hospital Pediatrics
|February 25, 2025
PubMed

Insights

Community hospitals can improve pediatric care by increasing participation in randomized clinical trials (RCTs). Fourteen strategies were identified to overcome barriers and enhance research in these settings.

Area of Science:

  • Pediatric Health Research
  • Clinical Trial Design
  • Health Services Research

Background:

  • Community hospitals deliver most US pediatric inpatient care but face research barriers.
  • Equitable research participation enhances pediatric care quality and generalizability.
  • Strategies are needed to boost community hospital involvement in pediatric clinical trials.

Purpose of the Study:

  • Identify strategies to increase community hospital participation in pediatric randomized clinical trials (RCTs).

Main Methods:

  • Convened an interdisciplinary panel of 33 experts (clinicians, parents, trialists, hospital staff).
  • Utilized a two-round nominal group technique for consensus building and strategy refinement.
  • Conducted descriptive and qualitative analyses of identified strategies.

Main Results:

  • Generated 119 initial ideas, refined to 14 specific strategies.
  • Identified three key domains: policy changes, centralized resources, and tailored research design.
  • Strategies focus on funding, review guidelines, resource systems, and adaptable trial planning.

Conclusions:

  • Developed 14 actionable strategies to support pediatric RCTs in community hospitals.
  • Implementation requires systemic changes in trial design, recruitment, funding, and investigation.
  • These changes are crucial for improving pediatric research equity and outcomes.
Abstract

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
6.7K
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
76
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
8.9K